References
- KrogerNAchterrathWHegewisch-BeckerSMrossKZanderARCurrent options in treatment of anthracycline-resistant breast cancerCancer Treat Rev199925527929110544072
- HigginsCFMultiple molecular mechanisms for multidrug resistance transportersNature2007446713774975717429392
- GilletJPGottesmanMMMechanisms of multidrug resistance in cancerMethods Mol Biol2010596477619949920
- BiedlerJLRiehmHCellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studiesCancer Res1970304117411845533992
- SodaniKPatelAKathawalaRJChenZSMultidrug resistance associated proteins in multidrug resistanceChin J Cancer2012312587222098952
- GattiLCossaGBerettaGLZaffaroniNPeregoPNovel insights into targeting ATP-binding cassette transporters for antitumor therapyCurr Med Chem201118274237424921838682
- McIlwainCCTownsendDMTewKDGlutathione S-transferase polymorphisms: cancer incidence and therapyOncogene200625111639164816550164
- CanteroGCampanellaCMateosSCortesFTopoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetinMutagenesis200621532132516950806
- LeeSKShehzadAJungJCProtein kinase C alpha protects against multidrug resistance in human colon cancer cellsMol Cells2012341616922639047
- ChenKGSikicBIMolecular pathways: regulation and therapeutic implications of multidrug resistanceClin Cancer Res20121871863186922344233
- BushJALiGCancer chemoresistance: the relationship between p53 and multidrug transportersInt J Cancer200298332333011920581
- BaguleyBCMultiple drug resistance mechanisms in cancerMol Biotechnol201046330831620717753
- ShapiraALivneyYDBroxtermanHJAssarafYGNanomedicine for targeted cancer therapy: towards the overcoming of drug resistanceDrug Resist Updat201114315016321330184
- HeQJGaoYZhangLXA pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistanceBiomaterials201132307711772021816467
- HuCMJZhangLFNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol20128381104111122285912
- LiNNZhaoLXQiLSLiZHLuanYXPolymer assembly: promising carriers as co-delivery systems for cancer therapyProg Polym Sci201658126
- ZhaoDWuJLiCZhangHLiZLuanYPrecise ratiometric loading of PTX and DOX based on redox-sensitive mixed micelles for cancer therapyColloid Surf B Biointerfaces2017155516028407531
- ZhangHWangKZhangPHeWSongALuanYRedox-sensitive micelles assembled from amphiphilic MPEG-PCL-SS-DTX conjugates for the delivery of docetaxelColloid Surf B Biointerfaces2016142899726938324
- Van VlerkenLEDuanZFSeidenMVAmijiMMModulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancerCancer Res200767104843485017510414
- MengHMaiWXZhangHYCodelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivoACS Nano201372994100523289892
- ChenYXuPFShuZMultifunctional graphene oxide-based triple stimuli-responsive nanotheranosticsAdv Funct Mater2014242843864396
- KanamalaMWilsonWRYangMMPalmerBDWuZMMechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a reviewBiomaterials20168515216726871891
- GuoYHeWYangSZhaoDLiZLuanYCo-delivery of docetaxel and verapamil by reduction-sensitive PEG-PLGA-SS-DTX conjugate micelles to reverse the multi-drug resistance of breast cancerColloid Surf B Biointerfaces201715111912727988472
- ZhaoDZhangHYangSHeWLuanYRedox-sensitive mPEG-SS-PTX/TPGS mixed micelles: an efficient drug delivery system for overcoming multidrug resistanceInt J Pharm20165151–228129227746331
- FreinbichlerWColivicchiMAStefaniniCHighly reactive oxygen species: detection, formation, and possible functionsCell Mol Life Sci201168122067207921533983
- PranczkJJacewiczDWyrzykowskiDChmurzynskiLAnalytical methods for determination of reactive oxygen speciesCurr Pharm Anal2014104293304
- TrachoothamDAlexandreJHuangPTargeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nat Rev Drug Discov20098757959119478820
- ZhouYHilemanEOPlunkettWKeatingMJHuangPFree radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agentsBlood2003101104098410412531810
- TsaoSMYinMCLiuWHOxidant stress and B vitamins status in patients with non-small cell lung cancerNutr Cancer200759181317927496
- SchumackerPTReactive oxygen species in cancer cells: live by the sword, die by the swordCancer Cell200610317517616959608
- CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidityMol Pharm20074346547417367162
- ShiehMJHsuCYHuangLYChenHYHuangFHLaiPSReversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cellsJ Control Release2011152341842521435362
- GuoYYChuMTanSWChitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistanceMol Pharm2014111597024229050
- ChenSYDongQHuSSProteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cellsMol Biosyst201410229430324292090
- EruslanovEKusmartsevSIdentification of ROS using oxidized DCFDA and flow-cytometryMethods Mol Boil20105945772
- ShanHQinglinZFengjunXYuxinLXiaochenCYuanHReversal of multidrug resistance of KBV200 cells by triterpenoids isolated from Poria cocosPlanta Med201278542843322457008
- CaoZLWrightMChengJKThe novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistanceOncol Rep20143231211121725017650
- SongCKBalakrishnanPShimCKChungSJKimDDEnhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cellsJ Microencapsul201128657558121770706
- SuZGChenMLXiaoYYROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor’s multidrug resistanceJ Control Release201419637038325278256
- SunFHuoXZhaiYJCrystal structure of mitochondrial respiratory membrane protein complex IICell200512171043105715989954
- AlmeidaJBallBAEffect of alpha-tocopherol and tocopherol succinate on lipid peroxidation in equine spermatozoaAnim Reprod Sci2005873–432133715911181
- YoukHJLeeEChoiMKEnhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycolJ Control Release20051071435216081183
- SiebelsIDroseSQ-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylatesBiochim Biophys Acta20131827101156116423800966
- SiemenDZiemerMWhat is the nature of the mitochondrial permeability transition pore and what is it not?IUBMB Life201365325526223341030
- SolaSMorgadoALRodriguesCMPDeath receptors and mitochondria: two prime triggers of neural apoptosis and differentiationBiochim Biophys Acta2013183012160216623041071
- PieczenikSRNeustadtJMitochondrial dysfunction and molecular pathways of diseaseExp Mol Pathol2007831849217239370
- HongWChenDWZhangXJReversing multidrug resistance by intracellular delivery of Pluronic (R) P85 unimersBiomaterials201334379602961424021757
- KimKMKimHMLeeWJSurface treatment of silica nanoparticles for stable and charge-controlled colloidal silicaInt J Nanomedicine20149Suppl 2294025565824
- LimbachLKLiYCGrassRNOxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrationsEnviron Sci Technol200539239370937616382966
- HonarySZahirFEffect of zeta potential on the properties of nano-drug delivery systems – a review (part 1)Trop J Pharm Res2013122255264
- MaedaHNakamuraHFangJThe EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivoAdv Drug Deliv Rev2013651717923088862
- BertrandNWuJXuXYKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
- ChoYWLeeJLeeSCHuhKMParkKHydrotropic agents for study of in vitro paclitaxel release from polymeric micellesJ Control Release200497224925715196752
- MinkoTBatrakovaEVLiSPluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cellsJ Control Release2005105326927815939500
- SharmavAKZhangLLiSPrevention of MDR development in leukemia cells by micelle-forming polymeric surfactantJ Control Release2008131322022718722489
- GuanFWangLAnti-tumor mechanisms of microtubule inhibitorsJ Int Pharm Res2014416623629
- JordanMATosoRJThrowerDWilsonLMechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrationsProc Natl Acad Sci U S A19939020955295568105478
- AhmedFPakunluRIBrannanABatesFMinkoTDischerDEBiodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drugJ Control Release2006116215015816942814
- NgSSWTsaoMSChowSHedleyDWInhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cellsCancer Res200060195451545511034087